Fig. 3From: Sustained response to pembrolizumab in recurrent perivascular epithelioid cell tumor with elevated expression of programmed death ligand: a case reportCT demonstrates metastatic disease involving a peripherally enhancing and centrally necrotic subaortic lymph node (arrow)Back to article page